Nasdaq · CIK 0001768267
CRNC Cerence Inc.
Insider trading from SEC Form 4. Last filing 2 d ago. Close $8.43 on Oct 9, 2026, +41% from the 52-week low and -36% from the high.
Last 90 days
Net insider value
-$2.1M
more sold than bought
Buys
1
$14k by 1 insider
Sells
5
$2.1M by 5 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
CRNCOct 9, 2026 · close 8.43
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Cerence Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Nils Schanz EVP Product & Technology sell | $420k 52,439 shares | -15% | +39% from low-37% from high | |
| 48Moderate | Jennifer Salinas EVP Chief Admin Officer sell | $529k 66,153 shares | -10% | +39% from low-37% from high | |
| 51Moderate | Christian Mentz EVP, Chief Revenue Officer sell | $391k 48,923 shares | -17% | +39% from low-37% from high | |
| 51Moderate | Brian M Krzanich Chief Executive Officer sell | $174k 21,703 shares | -1% | +39% from low-37% from high | |
| 25Weak | Antonio Rodriquez CFO buy | $14k 2,000 shares | +0% | +20% from low-43% from high | |
| 62Notable | Antonio Rodriquez CFO sell | $613k 76,614 shares | -13% | +39% from low-37% from high | |
| 30Weak | Christian Mentz EVP, Chief Revenue Officer sell | $53k 3,600 shares | -2% | - | |
| 10Weak | Thomas L Beaudoin director sell | $58k 5,000 shares | -3% | - | |
| 1Weak | Thomas L Beaudoin director sell | $40k 5,000 shares | -3% | - | |
| 16Weak | Thomas L Beaudoin director sell | $37k 5,000 shares | -3% | - | |
| 39Weak | Thomas L Beaudoin director sell | $87k 12,088 shares | -6% | - | |
| 23Weak | Jennifer Salinas EVP Chief Admin Officer sell | $254k 37,356 shares | -7% | - | |
| 30Weak | Katherine Roman VP Corporate Controller sell | $4,578 635 shares | -2% | - | |
| 0Weak | Thomas L Beaudoin director sell | $16k 5,000 shares | -2% | - |
Transactions
The last 25 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Jennifer Salinas EVP Chief Admin Officer | SOpen-market sale Common Stock | -66,153 | $8.00 | $529k | 627,876 | 2 d ago |
| Oct 7, 2026 | Christian Mentz EVP, Chief Revenue Officer | SOpen-market sale Common Stock | -48,923 | $8.00 | $391k | 244,551 | 2 d ago |
| Oct 7, 2026 | Brian M Krzanich Chief Executive Officer | SOpen-market sale Common Stock | -21,703 | $8.00 | $174k | 1,700,388 | 2 d ago |
| Feb 15, 2026 | Antonio Rodriquez CFO | POpen-market purchase Common Stock | +2,000 | $7.02 | $14k | 577,246 | 2 d ago |
| Oct 7, 2026 | Nils Schanz EVP Product & Technology | SOpen-market sale Common Stock | -52,439 | $8.00 | $420k | 290,243 | 2 d ago |
| Oct 7, 2026 | Antonio Rodriquez CFO | SOpen-market sale Common Stock | -76,614 | $8.00 | $613k | 500,632 | 2 d ago |
| Feb 13, 2025 | Christian Mentz EVP, Chief Revenue Officer | SOpen-market sale Common Stock | -3,600 | $14.73 | $53k | 142,747 | Feb 25, 2025 |
| Feb 13, 2025 | Alfred A Nietzel director | AGrant or award Common Stock | +9,955 | $0.01 | $100 | 42,198 | Feb 18, 2025 |
| Feb 13, 2025 | Douglas Lee Davis director | AGrant or award Common Stock | +9,955 | $0.01 | $100 | 26,576 | Feb 18, 2025 |
| Feb 13, 2025 | Marcy S Klevorn director | AGrant or award Common Stock | +9,955 | $0.01 | $100 | 22,436 | Feb 18, 2025 |
| Feb 13, 2025 | Arun Sarin director | AGrant or award Common Stock | +9,955 | $0.01 | $100 | 63,485 | Feb 18, 2025 |
| Feb 13, 2025 | Marianne Budnik director | AGrant or award Common Stock | +9,955 | $0.01 | $100 | 47,198 | Feb 18, 2025 |
| Feb 13, 2025 | Kristi Ann Matus director | AGrant or award Common Stock | +9,955 | $0.01 | $100 | 41,769 | Feb 18, 2025 |
| Feb 3, 2025 | Thomas L Beaudoin director | SOpen-market sale Common Stock10b5-1 | -5,000 | $11.68 | $58k | 173,966 | Feb 4, 2025 |
| Jan 13, 2025 | Nils Schanz EVP Product & Technology | AGrant or award Common Stock | +93,720 | $13.76 | $1.3M | 145,289 | Jan 15, 2025 |
| Jan 13, 2025 | Christian Mentz EVP, Chief Revenue Officer | AGrant or award Common Stock | +93,720 | $13.76 | $1.3M | 146,347 | Jan 15, 2025 |
| Jan 2, 2025 | Thomas L Beaudoin director | SOpen-market sale Common Stock10b5-1 | -5,000 | $7.98 | $40k | 178,966 | Jan 2, 2025 |
| Dec 6, 2024 | Antonio Rodriquez CFO | AGrant or award Common Stock | +313,283 | $8.31 | $2.6M | 313,283 | Dec 10, 2024 |
| Dec 2, 2024 | Thomas L Beaudoin director | SOpen-market sale Common Stock10b5-1 | -5,000 | $7.36 | $37k | 183,966 | Dec 3, 2024 |
| Nov 25, 2024 | Thomas L Beaudoin director | SOpen-market sale Common Stock | -12,088 | $7.21 | $87k | 188,966 | Nov 26, 2024 |
| Nov 25, 2024 | Jennifer Salinas EVP Chief Admin Officer | SOpen-market sale Common Stock | -8,976 | $7.21 | $65k | 517,447 | Nov 26, 2024 |
| Nov 25, 2024 | Katherine Roman VP Corporate Controller | SOpen-market sale Common Stock | -635 | $7.21 | $4,578 | 37,330 | Nov 26, 2024 |
| Nov 26, 2024 | Jennifer Salinas EVP Chief Admin Officer | SOpen-market sale Common Stock10b5-1 | -28,380 | $6.67 | $189k | 489,067 | Nov 26, 2024 |
| Nov 1, 2024 | Thomas L Beaudoin director | SOpen-market sale Common Stock10b5-1 | -5,000 | $3.11 | $16k | 201,054 | Nov 4, 2024 |
| Oct 11, 2024 | Brian M Krzanich Chief Executive Officer | AGrant or award Common Stock | +1,038,062 | $0.01 | $10k | 1,038,062 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Thomas L Beaudoindirector
- Marianne Budnikdirector
- Douglas Lee Davisdirector
- Marcy S Klevorndirector
- Brian M KrzanichChief Executive Officer
- Kristi Ann Matusdirector
- Christian MentzEVP, Chief Revenue Officer
- Alfred A Nietzeldirector
- Antonio RodriquezCFO
- Katherine RomanVP Corporate Controller
- Arun Sarindirector
- Jennifer SalinasEVP Chief Admin Officer
- Nils SchanzEVP Product & Technology
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.